Updated results and correlative FDG-PET analysis of a phase IB study of vemurafenib and cobimetinib (MEK inhibitor [GDC-0973]), in advanced BRAFV600- mutated melanoma (BRIM7).
| Image |  |
|---|---|
| Description | scientific article published on 6 May 2014 |
| Author/s |
author: Grant McArthur Igor Puzanov Antoni Ribas Thomas F. Gajewski |
| Publication date | May 6, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |